Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vestipitant

Generic Name: Vestipitant

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₄F_₇N_₃O

CAS Number: 334476-46-9

Unique Ingredient Identifier: S052TOI9BI

Overview

Vestipitant has been investigated for the treatment of Tinnitus.

Background

Vestipitant has been investigated for the treatment of Tinnitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)

Phase 2

Completed

Posted: 2012/01/10

Sponsor:Accenture

ID:NCT01507194

Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

Phase 2

Completed

Posted: 2006/10/31

Sponsor:GlaxoSmithKline

ID:NCT00394056

PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

Phase 2

Completed

Posted: 2006/06/23

Sponsor:GlaxoSmithKline

ID:NCT00343707

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Phase 2

Completed

Posted: 2002/10/30

Sponsor:GlaxoSmithKline

ID:NCT00048204

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy